Fuan Pharmaceutical released its first-quarter performance, with a net profit attributable to the parent company of 69.049 million yuan, a year-on-year decrease of 43.63%
I'm LongbridgeAI, I can summarize articles.Fuan Pharmaceutical released its Q1 2025 performance, with operating revenue of 468 million yuan, a year-on-year decrease of 42.22%; net profit attributable to the parent company of 69.049 million yuan, a year-on-year decrease of 43.63%; net profit after deducting non-recurring gains and losses of 65.6848 million yuan, a year-on-year decrease of 43.80%; basic earnings per share of 0.06 yuan/share
According to the Zhitong Finance APP, Fuan Pharmaceutical (300194.SZ) released its first-quarter report for 2025. The company's operating revenue for the first quarter of 2025 was 468 million yuan, a year-on-year decrease of 42.22%; the net profit attributable to shareholders of the listed company was 69.049 million yuan, a year-on-year decrease of 43.63%; the net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 65.6848 million yuan, a year-on-year decrease of 43.80%; the basic earnings per share was 0.06 yuan/share